News - Salspera

News
Recent news on Salspera
FDA GRANTS FAST TRACK DESIGNATION TO SALSPERA'S SALTIKVA, AN INNOVATIVE IMMUNOTHERAPEUTIC APPROACH TO TREAT METASTATIC PANCREATIC CANCER
June 1, 2022
Salspera today announced the U.S. Food and Drug Administration (FDA) granted Fast Track...
FDA GRANTS ORPHAN DRUG DESIGNATION (ODD) TO SALSPERA'S SALTIKVA, AN INNOVATIVE IMMUNOTHERAPEUTIC APPROACH TO TREAT METASTATIC PANCREATIC CANCER
May 23, 2022
Salspera today announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug...
Salspera Announces Positive Topline Data in Phase 2 Trial of Saltikva in Metastatic Pancreatic Cancer
September 27, 2021
Oakdale, MN, September 27th, 2021 – Salspera, LLC, a clinical stage biotechnology developing...
More Posts